Trial Profile
Clinical Trials Insight: 700058450
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 19 Aug 2010
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H5N1; Influenza virus vaccine
- Indications Influenza A virus H5N1 subtype; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- 19 Aug 2010 Status changed from not stated to planning.
- 12 Aug 2010 New trial record
- 12 Aug 2010 The trial is expected to begin in 2012, according to an Emergen BioSolutions media release.